Communications
Table 2). Intermediate 2 ([a]3D3 = ꢁ1.0 (CHCl3, c = 1.0)) was
Table 2: Selected physical properties for compounds 2, 11, 15, and 18.
2: Rf =0.43 (silica gel, EtOAc/hexanes 1:5); [a]3D3 =ꢁ1.0 (c=1.0, CHCl3);
thus obtained with 96% ee, as determined by chiral HPLC
(Chiralcel OD-H).
1
IR (film): n˜max =1731 cmꢁ1; H NMR (600 MHz, CDCl3): d=5.61 (dt,
J=15.0, 7.2 Hz, 1H), 5.36 (dd, J=15.0, 7.2 Hz, 1H), 3.68 (s, 3H), 3.54
(dd, J=6.6, 3.0 Hz, 1H), 3.26 (s, 3H), 2.85 (d, J=7.2 Hz, 1H), 2.13–1.80
(m, 9H), 1.73 (m, 1H), 1.57 (m, 1H), 1.45 (m, 1H), 1.33–1.17 (m, 7H),
0.86 ppm (t, J=7.2 Hz, 3H); 13C NMR (150 MHz, CDCl3): d=212.1,
171.4, 136.0, 124.5, 87.6, 69.4, 62.6, 58.3, 53.3, 52.7, 52.1, 36.8, 33.6,
32.1, 32.0, 29.8, 24.4, 23.3, 22.7, 22.4, 14.9 ppm; HRMS (ESI-TOF) (m/z):
calcd for C21H33O4+ [M+H]+: 349.2373; found: 349.2357
The methodology presented herein represents a conven-
ient entry into multifunctionalized and relatively complex
building blocks, starting from comparatively simple and
readily available starting materials. Its scope incorporates
substituted acyclic as well as cyclic ketones. Good to excellent
enantiomeric excess was attained in all cases studied.
Application of this catalytic asymmetric three-component
reaction to the construction of the spirocyclic domain of
vannusal A powerfully demonstrates the applicability and
versatility of this process. The total synthesis of this challeng-
ing triterpene 1 is well underway in our laboratories.
11: Rf =0.46 (silica gel, EtOAc/hexanes 1:5); [a]3D3 =+118.5 (c=1.0,
CHCl3); IR (film) n˜max =2957, 2929, 2855, 1684, 1611, 1458, 1326, 1286,
1
1208, 1122, 974, 938 cmꢁ1; H NMR (400 MHz, CDCl3): d=6.52 (t,
J=7.6 Hz, 1H), 5.51 (dd, J=15.7, 4.0 Hz, 1H), 5.30 (m, 1H), 3.60 (m,
1H), 2.59 (dt, J=13.5, 2.0 Hz, 1H), 2.46 (m, 1H), 2.11–1.97 (m, 5H),
1.88–1.79 (m, 1H), 1.78–1.70 (m, 2H), 1.59–1.50 (m, 1H), 1.49–1.20
(m, 11H), 0.92 (t, J=7.4 Hz, 3H), 0.87 ppm (t, J=6.8 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=216.2, 143.0, 140.0, 131.6, 130.7, 43.4,
37.8, 34.2, 32.7, 31.7, 30.0, 29.4, 28.8, 25.8, 25.1, 22.6, 22.1, 14.1,
14.0 ppm; HRMS (ESI TOF) (m/z): calcd for C19H33O+ [M+H]+:
277.2526; found: 277.2531
Experimental Section
General procedure: The alkyne (1.25 mmol, 1.25 equiv) was added to
[Cp2Zr(H)Cl][12] (1.2 mmol; 1.2 equiv) in anhydrous THF (4 mL)
under argon. The mixture was stirred at 258C for 30 min until it
became homogeneous. In a separate flask, [Rh(cod)(MeCN)2]BF4
(0.05 mmol, 0.05 equiv) and (S)-binap (0.06 mmol, 0.06 equiv) were
dissolved in anhydrous THF (4 mL) under argon and stirred at 258C
for 30 min. The enone (1.2 mmol, 1.2 equiv) was then added to the
resulting red catalyst solution, followed by the aldehyde (1.0 mmol;
1.0 equiv). The zirconium reagent was transferred to this solution
through a cannula, and the resulting mixture was stirred at 258C for
12 h. The mixture was concentrated under reduced pressure, and the
residue taken up in diethyl ether and directly filtered through a small
pad of celite and then concentrated. The resultant crude mixture was
purified by flash column chromatography (silica gel), with Et2O/
hexanes mixtures as eluant, to provide aldol products IV as colorless
oils. Triethylamine (1.8 mmol, 6.0 equiv) and methanesulfonyl chlo-
ride (0.9 mmol, 3.0 equiv) were added to a stirred solution of the aldol
product IV (0.3 mmol) in CH2Cl2 (4 mL) at 08C. The resulting
mixture was allowed to warm to 258C within 30 min, and then basic
alumina (2 g) was added (alternatively, DBU/THF could be
employed for the elimination step). The mixture was then stirred
vigorously at 258C for 12 h, filtered, and concentrated. The residue
was purified by flash column chromatography (silica gel) with EtOAc/
hexanes mixtures as eluant to provide enone product V.
15: Rf =0.41 (silica gel, EtOAc/hexanes 1:5); [a]3D3 =+73.5 (c=1.0,
CHCl3); IR (film) n˜max =2928, 2856, 1688, 1616, 1471, 1463, 1256, 1102,
970, 837, 776 cmꢁ1; 1H NMR (500 MHz, CDCl3): d=6.64 (t, J=7.5 Hz,
1H), 5.34 (dd, J=15.4, 4.8 Hz, 1H), 5.23 (m, 1H), 3.60 (m, 3H), 2.48 (d,
J=17.6 Hz, 1H), 2.23 (m, 2H), 2.08 (m, 1H), 1.96 (m, 2H), 1.91–1.78
(m, 3H), 1.78–1.71 (m, 1H), 1.68–1.56 (m, 2H), 1.32–1.20 (m, 8H), 0.88
(m, 12H), 0.03 ppm (s, 6H); 13C NMR (125 MHz, CDCl3): d=201.8,
140.2, 138.5, 131.9, 131.3, 62.4, 40.2, 38.6, 32.5, 31.7, 31.6, 29.8, 29.4,
28.8, 25.9, 24.1, 22.6, 19.0, 14.0, ꢁ5.3 ppm; HRMS (ESI-TOF) (m/z):
calcd for C24H45O2Si+ [M+H]+: 393.3183; found: 393.3184
18: Rf =0.38 (silica gel, EtOAc/hexanes 1:10); [a]3D3 =+44.6 (c=1.0,
1
CHCl3); IR (film): n˜ =1710 cmꢁ1; H NMR (400 MHz, CDCl3): d=5.37
(dt, J=14.8, 6.8 Hz, 1H), 5.21 (ddt, J=14.8, 9.6, 1.2 Hz, 1H), 3.92 (dd,
J=4.8, 2.4 Hz, 1H), 3.21 (s, 3H), 2.49 (m, 1H), 2.38–2.30 (m, 2H),
2.25–2.10 (m, 2H), 1.96–1.56 (m, 8H), 1.45 (m, 1H), 1.37–1.18 (m, 9H),
0.85 ppm (t, J=6.8 Hz, 3H); 13C NMR (150 MHz, CDCl3): d=212.8,
133.9, 129.7, 88.3, 65.3, 57.4, 48.7, 42.1, 33.3, 32.5, 30.2, 30.0, 29.9, 29.6,
29.6, 23.6, 23.5, 21.6, 14.9 ppm; HRMS (ESI-TOF) (m/z): calcd for
C19H33O2+ [M+H]+: 293.2471; found: 293.2475
Received: March 3, 2005
Published online: May 18, 2005
Shibasaki, J. Org. Chem. 1998, 63, 3666 – 3672; b) L. A. Arnold,
R. Naasz, A. J. Minnaard, B. L. Feringa, J. Am. Chem. Soc. 2001,
123, 5841 – 5842; c) L. A. Arnold, R. Naasz, A. J. Minnaard, B. L.
Feringa, J. Org. Chem. 2002, 67, 7244 – 7254.
Keywords: aldol reaction · asymmetric catalysis ·
.
multicomponent reactions · natural products ·
nucleophilic addition
[4] G. Guella, F. Nini, F. Pietra, Angew. Chem. 1999, 111, 1217 –
1220; Angew. Chem. Int. Ed. 1999, 38, 1134 – 1136.
[5] S. Oi, T. Sato, Y. Inoue, Tetrahedron Lett. 2004, 45, 5051 – 5055.
[6] a) K. Yoshida, M. Ogasawara, T. Hayashi, J. Am. Chem. Soc.
2002, 124, 10984 – 10985; b) T. Hayashi, K. Yamasaki, Chem.
Rev. 2003, 103, 2829 – 2844.
[7] J. Schwartz, J. A. Labinger, Angew. Chem. 1976, 88, 402 – 409;
Angew. Chem. Int. Ed. Engl. 1976, 15, 333 – 340.
[8] B. H. Lipshutz, J. Keith, P. Papa, R. Vivian, Tetrahedron Lett.
1998, 39, 4627 – 4630.
[9] For previous examples of aldol reactions mediated by rhodium
enolates, see: a) G. A. Slough, R. G. Bergman, C. H. Heathcock,
J. Am. Chem. Soc. 1989, 111, 938 – 949; b) S. J. Taylor, M. O.
Duffey, J. P. Morken, J. Am. Chem. Soc. 2000, 122, 4528 – 4529;
c) H.-Y. Jang, R. R. Huddleston, M. J. Krische, J. Am. Chem.
Soc. 2002, 124, 15156 – 15157; d) H.-Y. Jang, M. J. Krische, Acc.
Chem. Res. 2004, 37, 653 – 661; e) H.-Y. Jang, M. J. Krische, Eur.
J. Org. Chem. 2004, 3953 – 3958; f) A. E. Russell, N. O. Fuller,
[1] For selected reviews on multicomponent reactions, see: a) L.
Weber, K. Illgen, M. Almstetter, Synlett 1999, 366 – 374; b) H.
Bienaymꢀ, C. Hulme, G. Oddon, P. Schmitt, Chem. Eur. J. 2000,
6, 3321 – 3329; c) L. Weber, Curr. Opin. Chem. Biol. 2000, 4,
295 – 302; d) L. Weber, Drug Discovery Today 2002, 7, 143 – 147;
e) A. Tuch, S. Wallꢀ, Handbook of Combinatorial Chemistry,
Vol. 2 (Eds.: K. C. Nicolaou, R. Hanko, W. Hartwig), Wiley-
VCH, Weinheim, 2002, pp. 685 – 705; f) R. V. A. Orru, M.
de Greef, Synthesis 2003, 1471 – 1499.
[2] For an excellent review on asymmetric multicomponent reac-
tions, see: M. Yus, D. J. Ramꢁn, Angew. Chem. 2005, 117, 1602 –
1634; Angew. Chem. Int. Ed. 2005, 44, 1628 – 1661.
[3] For examples of catalytic asymmetric 1,4-addition/aldol reac-
tions involving cyclic enones, see: a) K.-I. Yamada, T. Arai, M.
3878
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Angew. Chem. Int. Ed. 2005, 44, 3874 –3879